Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

Authors

Surender Khurana

Published

January 20, 2010

Abstract

An oil-based adjuvant improves the efficacy of an H5N1 vaccine by inducing antibodies against additional sites on influenza surface proteins.

Supporters

Support the authors with ResearchCoin

Journal

Science Translational Medicine

Topics

Biology

Epidemiology

Immunology

Agronomy And Crop Science

Influenza Vaccine

DOI

10.1126/scitranslmed.3000624

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

Authors

Surender Khurana

Published

January 20, 2010

Abstract

An oil-based adjuvant improves the efficacy of an H5N1 vaccine by inducing antibodies against additional sites on influenza surface proteins.

Supporters

Support the authors with ResearchCoin

Journal

Science Translational Medicine

Topics

Biology

Epidemiology

Immunology

Agronomy And Crop Science

Influenza Vaccine

DOI

10.1126/scitranslmed.3000624

Paper

Paper

Paper

Paper

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

Abstract

Supporters

Journal

Topics

DOI

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

Abstract

Supporters

Journal

Topics

DOI